An examination of survival by sex and race in the HeartWare Ventricular Assist Device for the Treatment of Advanced Heart Failure (ADVANCE) Bridge to Transplant (BTT) and continued access protocol trials
Emma J. Birks(Lung Institute), Mark S. Slaughter(University of Louisville), Kevin B. Najarian(Heartware International (United States)), Francis D. Pagani(Michigan Medicine), Steven W. Boyce(George Washington University Hospital), William Cotts, Keith D. Aaronson(University of Michigan), David R. Hathaway(University of Chicago), Samer S. Najjar(University of Tennessee Health Science Center), Edwin C. McGee(University of Chicago), Mary V. Jacoski(Heartware International (United States))
Cited by 43
Related Papers
Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults
|Circulation|2005|1.2k
Genome-wide association study identifies eight loci associated with blood pressure
|Nature Genetics|2009|1.2k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711